查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1416430

生物標記市場報告：2030 年趨勢、預測與競爭分析

Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

生物標記趨勢和預測

預計到 2030 年，全球生物標記市場將達到 1,105 億美元，2024 年至 2030 年複合年成長率為 8.8%。該市場的主要促進因素是對個人化醫療的日益偏好以及政府對生物標記研究和開發的支持不斷增加。全球生物標記市場的未來看起來充滿希望，診斷、藥物發現和開發、個人化醫療和疾病風險評估市場充滿機會。

生物標記市場洞察

Lucintel 預計，在整個預測期內，消耗品仍將是最大的細分市場。

在這個市場中，診斷在整個預測期內仍將是最大的細分市場。

由於慢性病人口不斷成長以及該地區主要參與者的存在，北美將繼續成為最大的地區。

常問問題

Q.1 生物標記的市場規模有多大？

A1. 到 2030 年，全球生物標記市場預計將達到 1,105 億美元。

Q.2 生物標記市場的成長預測為何：

A2. 2024年至2030年，全球生物標記市場預計將以8.8%的複合年成長率成長。

Q.3 影響生物標記市場成長的關鍵因素有哪些：

A3. 該市場的主要驅動力是對個人化醫療的日益偏好以及政府對生物標記研究和開發的支持不斷增加。

Q4.市場的主要細分市場是：

A4. 生物標記市場的未來前景廣闊，診斷、藥物發現和開發、個人化醫療和疾病風險評估市場充滿機會。

Q5.市場的主要企業是：

A5. 一些主要的生物標記公司是：

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計，在整個預測期內，消耗品仍將是其最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於慢性病人口不斷成長以及該地區主要參與者的存在，北美將繼續成為最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球生物標記市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球生物標記市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品分類的全球生物標記市場
    • 消耗品
    • 服務
    • 軟體
  • 按類型分類的全球生物標記市場
    • 安全生物標記
    • 功效生物標記
    • 預測性生物標記
    • 替代生物標記
    • 動態生物標記
    • 預後生物標記
    • 檢驗生物標記
  • 按疾病適應症分類的全球生物標記市場
    • 癌症
    • 感染疾病
    • 免疫疾病
    • 神經系統疾病
    • 心血管疾病
    • 其他
  • 按應用分類的全球生物標記市場
    • 診斷
    • 藥物發現與開發
    • 個人化醫療
    • 疾病風險評估
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的全球生物標記市場
  • 北美生物標誌市場
  • 歐洲生物標記市場
  • 亞太生物標記市場
  • 其他地區生物標記市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球生物標記物市場成長機會（按產品）
    • 按類型分類的全球生物標記市場成長機會
    • 按疾病適應症分類的全球生物標記市場成長機會
    • 全球生物標記物市場成長機會（按應用）
    • 按地區分類的全球生物標記市場成長機會
  • 全球生物標記市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球生物標記物市場的產能
    • 全球生物標記市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific
簡介目錄

Biomarker Trends and Forecast

The future of the global biomarker market looks promising with opportunities in the diagnostic, drug discovery & development, personalized medicine, and disease risk assessment markets. The global biomarker market is expected to reach an estimated $110.5 billion by 2030 with a CAGR of 8.8% from 2024 to 2030. The major drivers for this market are growing preference for personalized medicine and rising government support for biomarker research and development.

A more than 150-page report is developed to help in your business decisions.

Biomarker by Segment

The study includes a forecast for the global biomarker by product, type, disease indication, application, and region.

Biomarker Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Consumables
  • Services
  • Software

Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Safety Biomarkers
  • Efficacy Biomarkers
  • Predictive Biomarkers
  • Surrogate Biomarkers
  • Pharmacodynamics Biomarkers
  • Prognostic Biomarkers
  • Validation Biomarkers

Biomarker Market by Disease Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer
  • Infectious Diseases
  • Immune Disorders
  • Neurological Disorders
  • Cardiovascular Disorders
  • Others

Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicine
  • Disease Risk Assessment
  • Others

Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biomarker companies profiled in this report include-

  • Abbott Laboratories
  • QIAGEN
  • Perkinelmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Biomarker Market Insights

Lucintel forecasts that consumable will remain the largest segment over the forecast period.

Within this market, diagnostic will remain the largest segment over the forecast period.

North America will remain the largest region due to growing number of population with chronic diseases and presence of key players in the region.

Features of the Global Biomarker Market

Market Size Estimates: Biomarker Market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biomarker Market by various segments, such as by product, type, disease indication, application and region in terms of($B).

Regional Analysis: Biomarker Market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, types, disease indications, applications, and regions for the biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the biomarker market size?

Answer: The global biomarker market is expected to reach an estimated $110.5 billion by 2030.

Q.2 What is the growth forecast for biomarker market?

Answer: The global biomarker market is expected to grow with a CAGR of 8.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the biomarker market?

Answer: The major drivers for this market are growing preference for personalized medicine and rising government support for biomarker research and development.

Q4. What are the major segments for biomarker market?

Answer: The future of the biomarker market looks promising with opportunities in the diagnostic, drug discovery & development, personalized medicine, and disease risk assessment markets.

Q5. Who are the key Biomarker Market companies?

Answer: Some of the key biomarker companies are as follows:

  • Abbott Laboratories
  • QIAGEN
  • PerkinElmer
  • Merck
  • Bio-Rad Laboratories
  • Enzo Biochem
  • Charles River Laboratories
  • Siemens
  • Epistem
  • Eurofins Scientific

Q6. Which biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that consumable will remain the largest segment over the forecast period.

Q7. In biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to growing number of population with chronic diseases and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the biomarker market by product (consumables, services, and software), type (safety biomarkers, efficacy biomarkers, predictive biomarkers, surrogate biomarkers, pharmacodynamics biomarkers, prognostic biomarkers, and validation biomarkers), disease indication (cancer, infectious diseases, immune disorders, neurological disorders, cardiovascular disorders, and others), application (diagnostics, drug discovery & development, personalized medicine, disease risk assessment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Biomarker Market by Product
    • 3.3.1: Consumables
    • 3.3.2: Services
    • 3.3.3: Software
  • 3.4: Global Biomarker Market by Type
    • 3.4.1: Safety Biomarkers
    • 3.4.2: Efficacy Biomarkers
    • 3.4.3: Predictive Biomarkers
    • 3.4.4: Surrogate Biomarkers
    • 3.4.5: Pharmacodynamics Biomarkers
    • 3.4.6: Prognostic Biomarkers
    • 3.4.7: Validation Biomarkers
  • 3.5: Global Biomarker Market by Disease Indication
    • 3.5.1: Cancer
    • 3.5.2: Infectious Diseases
    • 3.5.3: Immune Disorders
    • 3.5.4: Neurological Disorders
    • 3.5.5: Cardiovascular Disorders
    • 3.5.6: Others
  • 3.6: Global Biomarker Market by Application
    • 3.6.1: Diagnostics
    • 3.6.2: Drug Discovery & Development
    • 3.6.3: Personalized Medicine
    • 3.6.4: Disease Risk Assessment
    • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Biomarker Market by Region
  • 4.2: North American Biomarker Market
    • 4.2.2: North American Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.3: European Biomarker Market
    • 4.3.1: European Biomarker Market by Product: Consumables, Services, and Software
    • 4.3.2: European Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.4: APAC Biomarker Market
    • 4.4.1: APAC Biomarker Market by Product: Consumables, Services, and Software
    • 4.4.2: APAC Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others
  • 4.5: ROW Biomarker Market
    • 4.5.1: ROW Biomarker Market by Product: Consumables, Services, and Software
    • 4.5.2: ROW Biomarker Market by Application: Diagnostics, Drug Discovery & Development, Personalized Medicine, Disease Risk Assessment, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Biomarker Market by Product
    • 6.1.2: Growth Opportunities for the Global Biomarker Market by Type
    • 6.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
    • 6.1.4: Growth Opportunities for the Global Biomarker Market by Application
    • 6.1.5: Growth Opportunities for the Global Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: QIAGEN
  • 7.3: PerkinElmer
  • 7.4: Merck
  • 7.5: Bio-Rad Laboratories
  • 7.6: Enzo Biochem
  • 7.7: Charles River Laboratories
  • 7.8: Siemens
  • 7.9: Epistem
  • 7.10: Eurofins Scientific